Inactive Instrument

Press Releases Akili, Inc.

Stocks

AKLI

US00974B1070

Advanced Medical Equipment & Technology

Press Releases

24-08-15	Aura Appoints Dr. Scott Kollins Chief Medical Officer	AQ
24-06-18	Akili Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video Game	BU
24-05-29	Virtual Therapeutics, Akili Interactive Enter Into Definitive Merger Agreement to Establish Leading Digital Health Company	BU
24-05-14	Akili Reports First Quarter 2024 Financial Results and Provides Business Update	BU
24-04-30	Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results	BU
24-02-29	Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	BU
24-02-27	Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx for Pediatric ADHD Patients in Japan	AQ
24-02-26	Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan	BU
24-02-21	Akili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance Updates	BU
23-12-18	EndeavorRxⓇ, World’s First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17	BU
23-11-21	Ubongo Takes Digital Literacy Campaign to Burera	AQ
23-11-09	Akili Reports Third Quarter 2023 Financial Results and Provides Business Update	BU
23-10-19	Akili to Host Third Quarter Financial Results Conference Call and Webcast on Thursday, November 9 at 4:30 p.m. ET	BU
23-10-13	Employees with ADHD Aren't Reaching Their Full Potential at Work, Akili Study Finds	AQ
23-10-12	Employees with ADHD Aren’t Reaching Their Full Potential at Work, Akili Study Finds	BU
23-10-09	Akili Announces Leadership Transition	AQ
23-10-06	Akili Announces Leadership Transition	BU
23-09-21	Akili Releases EndeavorOTC™ on Android™ Devices, Expanding Treatment Access for Millions of Adults with ADHD	BU
23-09-14	Akili : Market Update Analyst Call Presentation	PU
23-09-13	Akili Announces Business Transformation, Focusing on Non-prescription Model	BU
23-08-10	Akili : Q2-23 Earnings Presentation	PU
23-08-10	Akili Reports Second Quarter 2023 Financial Results and Provides Business Update	BU
23-07-10	Akili to Host Second Quarter Financial Results Conference Call and Webcast on Thursday, August 10 at 4:30 p.m. ET	BU
23-06-07	AKILI, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
23-06-07	Akili Releases EndeavorOTCTM Video Game Treatment to Improve Attention in Adults with ADHD	BU